What causes high prolactin levels?

High prolactin levels can result from various causes including pituitary tumors, medications, thyroid disorders, stress, and pregnancy. Understanding the underlying cause is crucial for proper treatment and management of symptoms like irregular periods, infertility, and unexpected breast milk production.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Prolactin and Its Role in Your Body

Prolactin is a hormone primarily produced by the pituitary gland, a small pea-sized structure at the base of your brain. While most people associate prolactin with breastfeeding and milk production, this versatile hormone plays multiple roles in both men and women, influencing reproductive health, immune function, and metabolic processes.

Normal prolactin levels typically range from 4-23 ng/mL in non-pregnant women and 3-15 ng/mL in men. When levels exceed these ranges, a condition called hyperprolactinemia develops, which can lead to various symptoms and health complications. Understanding what causes prolactin levels to rise is essential for proper diagnosis and treatment.

Common Medical Causes of Elevated Prolactin

Pituitary Tumors (Prolactinomas)

The most common pathological cause of high prolactin levels is a benign tumor of the pituitary gland called a prolactinoma. These tumors account for approximately 40% of all pituitary tumors and can vary in size from microadenomas (less than 10mm) to macroadenomas (greater than 10mm). Prolactinomas directly secrete excess prolactin into the bloodstream, with larger tumors typically producing higher hormone levels.

Common Medications That Raise Prolactin Levels

Medication ClassExamplesTypical Prolactin ElevationMechanism
AntipsychoticsTypical AntipsychoticsHaloperidol, ChlorpromazineOften >100 ng/mLStrong dopamine receptor blockade
Atypical AntipsychoticsAtypical AntipsychoticsRisperidone, Paliperidone50-150 ng/mLDopamine receptor antagonism
AntidepressantsSSRIs/TCAsSertraline, Amitriptyline25-50 ng/mLSerotonin-mediated stimulation
GI MedicationsAntiemeticsMetoclopramide, Domperidone25-100 ng/mLDopamine antagonism
AntihypertensivesCalcium Channel BlockersVerapamil25-50 ng/mLUnclear, possible dopamine effects

Prolactin elevation varies by individual. Levels shown are typical ranges but can differ based on dose and duration of use.

Prolactinomas are more common in women than men and often present differently between the sexes. Women typically seek medical attention earlier due to menstrual irregularities, while men may not notice symptoms until the tumor grows large enough to cause headaches or vision problems. The good news is that most prolactinomas respond well to medical treatment with dopamine agonists.

Hypothyroidism and Thyroid Disorders

An underactive thyroid gland (hypothyroidism) is another significant cause of elevated prolactin levels. When thyroid hormone levels are low, the hypothalamus releases more thyrotropin-releasing hormone (TRH) to stimulate thyroid function. However, TRH also stimulates prolactin release from the pituitary gland, leading to hyperprolactinemia in about 40% of people with primary hypothyroidism.

This connection between thyroid function and prolactin highlights the importance of comprehensive hormone testing when evaluating high prolactin levels. Treating the underlying thyroid disorder often normalizes prolactin levels without requiring additional intervention. Regular monitoring of both thyroid hormones and prolactin can help ensure optimal treatment outcomes.

Kidney and Liver Disease

Chronic kidney disease can cause prolactin levels to rise due to decreased clearance of the hormone from the body. The kidneys normally help eliminate prolactin, and when their function is impaired, prolactin can accumulate in the bloodstream. Studies show that up to 80% of patients with end-stage renal disease have elevated prolactin levels.

Similarly, liver cirrhosis can lead to hyperprolactinemia through altered hormone metabolism and increased estrogen levels, which stimulate prolactin production. The severity of prolactin elevation often correlates with the degree of liver dysfunction.

Medications That Increase Prolactin Levels

Numerous medications can cause drug-induced hyperprolactinemia by interfering with dopamine, the primary inhibitor of prolactin secretion. Understanding these medication effects is crucial because drug-induced hyperprolactinemia is reversible and often resolves after discontinuing or switching the offending medication.

Psychiatric Medications

Antipsychotic medications, particularly older typical antipsychotics like haloperidol and chlorpromazine, are among the most common causes of medication-induced hyperprolactinemia. These drugs block dopamine receptors in the pituitary gland, removing the normal inhibition of prolactin release. Even newer atypical antipsychotics, especially risperidone and paliperidone, can significantly elevate prolactin levels.

Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants, can also raise prolactin levels, though usually to a lesser extent than antipsychotics. The mechanism involves serotonin's stimulatory effect on prolactin secretion.

Other Common Medications

  • Metoclopramide and domperidone (anti-nausea medications)
  • H2 receptor blockers like cimetidine and ranitidine
  • Calcium channel blockers, particularly verapamil
  • Opioid pain medications
  • Estrogen-containing contraceptives and hormone replacement therapy

Physiological and Lifestyle Factors

Pregnancy and Breastfeeding

During pregnancy, prolactin levels naturally increase 10-20 fold to prepare the breasts for lactation. This physiological hyperprolactinemia is normal and expected. Prolactin levels remain elevated throughout breastfeeding, with surges occurring during nursing sessions. These elevated levels help maintain milk production and suppress ovulation, providing natural (though not foolproof) contraception during exclusive breastfeeding.

Stress and Physical Factors

Both physical and psychological stress can temporarily elevate prolactin levels. This includes acute stressors like surgery, seizures, or intense exercise, as well as chronic psychological stress. The stress response activates various neuroendocrine pathways that can stimulate prolactin release.

Other physical factors that can raise prolactin include:

  • Chest wall irritation or trauma (through neural pathways similar to those activated during breastfeeding)
  • Sleep (prolactin levels naturally rise during sleep and peak in the early morning)
  • Sexual activity
  • High-protein meals

Less Common Causes of High Prolactin

Polycystic Ovary Syndrome (PCOS)

While not a primary feature of PCOS, mild prolactin elevation occurs in approximately 30% of women with this condition. The exact mechanism isn't fully understood but may relate to altered dopamine regulation or the hormonal imbalances characteristic of PCOS. The prolactin elevation in PCOS is typically mild (less than 50 ng/mL) compared to the marked elevations seen with prolactinomas.

Other Pituitary and Hypothalamic Disorders

Various conditions affecting the pituitary gland or hypothalamus can cause high prolactin levels by disrupting the normal dopamine inhibition of prolactin secretion. These include:

  • Non-functioning pituitary adenomas that compress the pituitary stalk
  • Craniopharyngiomas
  • Meningiomas
  • Sarcoidosis or other infiltrative diseases
  • Head trauma affecting the hypothalamic-pituitary region
  • Radiation therapy to the brain

Recognizing Symptoms of High Prolactin

The symptoms of hyperprolactinemia vary between men and women and depend on the degree of prolactin elevation and its underlying cause. In women, the most common symptoms include irregular or absent menstrual periods, unexpected breast milk production (galactorrhea), infertility, and decreased libido. Women may also experience vaginal dryness due to the suppression of estrogen that occurs with high prolactin levels.

Men with high prolactin often experience erectile dysfunction, decreased libido, infertility, and in some cases, breast enlargement (gynecomastia) and milk production. Because these symptoms can develop gradually and may be attributed to aging or stress, men often have significant delays in diagnosis. Both sexes may experience headaches and vision problems if a large pituitary tumor is present. Understanding your hormone levels through comprehensive testing can help identify these issues early and guide appropriate treatment.

Diagnostic Approach and Testing

Diagnosing the cause of high prolactin requires a systematic approach. Initial testing should include a fasting morning prolactin level, as this minimizes physiological variations. If elevated, the test should be repeated to confirm the finding, as prolactin can be transiently elevated due to stress, recent meals, or physical activity.

Additional testing typically includes:

  • Thyroid function tests (TSH, Free T4) to rule out hypothyroidism
  • Pregnancy test in women of reproductive age
  • Kidney and liver function tests
  • Review of all medications and supplements
  • MRI of the pituitary gland if prolactin levels are significantly elevated or if other pituitary hormones are affected

The degree of prolactin elevation can provide clues to the underlying cause. Levels above 200 ng/mL strongly suggest a prolactinoma, while mild elevations (25-100 ng/mL) are more likely due to medications, stress, or other non-tumor causes.

Treatment Options and Management Strategies

Treatment of high prolactin depends entirely on identifying and addressing the underlying cause. For prolactinomas, dopamine agonist medications like cabergoline or bromocriptine are highly effective, normalizing prolactin levels and shrinking tumors in most cases. These medications work by mimicking dopamine's inhibitory effect on prolactin secretion.

For medication-induced hyperprolactinemia, the approach involves weighing the benefits of the causative medication against the side effects of high prolactin. Sometimes, switching to an alternative medication with less effect on prolactin or adding a dopamine agonist can help manage symptoms while maintaining necessary treatment.

When hypothyroidism is the cause, thyroid hormone replacement typically normalizes prolactin levels within a few months. Similarly, treating underlying kidney or liver disease, when possible, can help reduce prolactin levels.

Taking Control of Your Hormonal Health

High prolactin levels can significantly impact your quality of life, affecting everything from reproductive health to emotional well-being. The key to successful management lies in accurate diagnosis and appropriate treatment of the underlying cause. Whether due to a pituitary tumor, medication side effect, or other medical condition, most cases of hyperprolactinemia can be effectively treated.

If you're experiencing symptoms suggestive of high prolactin, don't hesitate to seek medical evaluation. Early detection and treatment can prevent complications and restore hormonal balance. Regular monitoring of your hormone levels, especially if you have risk factors or are taking medications known to affect prolactin, can help catch problems early and ensure optimal health outcomes.

References

  1. Melmed, S., Casanueva, F. F., Hoffman, A. R., Kleinberg, D. L., Montori, V. M., Schlechte, J. A., & Wass, J. A. (2011). Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 96(2), 273-288.[Link][DOI]
  2. Vilar, L., Vilar, C. F., Lyra, R., & Freitas, M. D. C. (2019). Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology, 109(1), 7-19.[PubMed][DOI]
  3. Torre, D. L., & Falorni, A. (2007). Pharmacological causes of hyperprolactinemia. Therapeutics and Clinical Risk Management, 3(5), 929-951.[PubMed]
  4. Samperi, I., Lithgow, K., & Karavitaki, N. (2019). Hyperprolactinaemia. Journal of Clinical Medicine, 8(12), 2203.[PubMed][DOI]
  5. Capozzi, A., Scambia, G., Pontecorvi, A., & Lello, S. (2015). Hyperprolactinemia: pathophysiology and therapeutic approach. Gynecological Endocrinology, 31(7), 506-510.[PubMed][DOI]
  6. Majumdar, A., & Mangal, N. S. (2013). Hyperprolactinemia. Journal of Human Reproductive Sciences, 6(3), 168-175.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my prolactin at home?

You can test your prolactin at home with SiPhox Health's Hormone Focus Program, which includes prolactin testing along with other key hormone biomarkers. For women specifically, the Women's Essential Hormone Panel includes prolactin testing alongside other reproductive hormones.

What is considered a dangerously high prolactin level?

Prolactin levels above 200 ng/mL are considered significantly elevated and strongly suggest a prolactinoma. Levels above 500 ng/mL almost always indicate a macroprolactinoma. However, any persistent elevation above the normal range (23 ng/mL for women, 15 ng/mL for men) warrants medical evaluation.

Can high prolactin levels go away on their own?

It depends on the cause. Stress-related or exercise-induced elevations typically resolve on their own. Medication-induced high prolactin may normalize after stopping the drug. However, prolactinomas and other medical causes require treatment. Physiological causes like pregnancy and breastfeeding will normalize after delivery or weaning.

What foods should I avoid if I have high prolactin?

While diet doesn't directly cause high prolactin, some foods may influence levels. Consider limiting alcohol, which can affect hormone balance, and foods high in phytoestrogens like soy if you're sensitive. Focus on a balanced diet rich in vitamin B6, vitamin E, and zinc, which support healthy prolactin regulation.

How long does it take for prolactin levels to normalize with treatment?

With dopamine agonist treatment for prolactinomas, prolactin levels often begin dropping within days to weeks, with normalization typically occurring within 3-6 months. For medication-induced cases, levels usually normalize within 3-4 days of stopping the drug. Thyroid-related cases may take 2-3 months to normalize with thyroid treatment.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details